About ReBuilder Medical Technologies Inc

Led by more than 300 investment professionals, EvergreenInvestments strives to meet client investment objectives through disciplined,team-based asset management. For more information onEvergreen, please visit EvergreenInvestments .Funds: NOT FDIC INSURED NOT BANK GUARANTEED MAY LOSE VALUESOURCEEvergreen InvestmentsShareholder Inquiries: 1-800-730-6001, or Financial Advisor Inquiries:1-800-343-2898; Media Inquiries: Lauren Sawyers, 1-704-715-4561,, or Laura Fay, 1-617-210-3867,, all for Evergreen Investments. ITEXPO "The World's Communications Conference" expects more than 7,000industry professionals.PHILADELPHIA, Jan. McFadden, will be giving a presentation entitled "The Hidden ContactCenter" on Monday February 2nd at 7:00 PM in the main Presentation Theatre Mr. McFadden will also be participating in a panel session entitled"Enterprise Pitfalls: Lessons Learned" to be held the same day at 4:00 PM.About InfradaptInfradapt is a leading regional technology solutions firm, providingcomprehensive IT consulting and outsourcing.Its customers span manyindustries from small-to-mid sized businesses to multi-location Fortune-1000enterprises.Infradapt's solutions range from basic IT services throughmulti-tier outsourced support and business continuity solutions.Infradapthas a strong IP Telephony (VoIP) service concentration, specializing indesigning, integrating, and supporting converged voice networks includingmulti-site and call center systems.Recognized nationally for service andengineering excellence, Infradapt is the company experts choose. S. McFadden of Infradapt, 1-800-394-2301, .

CHARLES TOWN, W.Va., Jan. 16 /PRNewswire-FirstCall/ The US neuropathic painmarket consists of 4.7 million patients, and is expected to grow to more than6.1 million patients, and be valued at $5.1 billion in 2018.(Logo: http://)David B Phillips, Ph.D. reports "We have not experienced the same economicdown turn as other businesses because our market is growing."John Johnson, Marketing Manager, has increased the ability of the company toexpand its sales department in a novel way."We have provided our insidesales reps with a special VOIP phone to use at home that give them the sameaccess to answering the phone as they have in the office.We pay them on acommission basis and that has given us more sales at less cost.I fullyexpect sales to move to $6 million in 2009."About ReBuilder Medical Technologies, Inc.:ReBuilder Medical Technologies, Inc (Pink Sheets: RBRM) is an emerging medicaldevice manufacturer of innovative technologies founded by world renownedmedical device inventor David B Phillips, Ph.D. ReBuilder Medical's flagshipproduct is its FDA registered ReBuilder System for treating peripheralneuropathy.Unlike current therapies for neuropathy (nerve disease) whichfocus on prescription drugs with powerful side effects, the ReBuilderSystem(R) is a portable, battery powered medical product that provides a newnon-surgical treatment for diabetic peripheral neuropathy which isnon-invasive, has no side effects and can actually strengthen muscles whileincreasing blood flow.

More information on ReBuilder Medical and its neuropathy products can be foundat: Safe Harbor: This letter contains certain forward-looking statements withinthe meaning of Section 27A of the Securities Act of 1933, as amended andSection 21E of the Securities Exchange Act of 1934, as amended, which areintended to be covered by the safe harbors created thereby. Investors arecautioned that all forward-looking statements involve risks and uncertainty,including without limitation, the ability of the Company to successfullyimplement its turnaround strategy, changes in costs of raw materials, labor,and employee benefits, as well as general market conditions, competition andpricing. Although the Company believes that the assumptions underlying theforward-looking statements contained herein are reasonable, any of theassumptions could be inaccurate, and therefore, there can be no assurance thatthe forward-looking statements included in this letter will prove to beaccurate. In light of the significant uncertainties inherent in theforward-looking statements included herein, the inclusion of such informationshould not be regarded as representation by the Company or any other personthat the objectives and plans of the Company will be achieved. When used in the Annual Report on Form 10-K, the words"estimate," "anticipate," "expect," "believe," and similar expressions areintended to be forward-looking statements.SOURCEReBuilder Medical Technologies, Inc.David B Phillips, Ph.D of ReBuilder Medical Technologies, Inc.,1-304-725-2202.